Biologic monotherapy in the treatment of rheumatoid arthritis

Biologics, possibly in combination with a conventional disease-modifying antirheumatic drug (DMARD) – preferably methotrexate (MTX), are used in accordance with the recommendations of the international rheumatological societies. However, in clinical practice, this recommendation is often problematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Detert, Jacqueline, Klaus, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440355/
https://www.ncbi.nlm.nih.gov/pubmed/26028960
http://dx.doi.org/10.2147/BTT.S53361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440355/
https://www.ncbi.nlm.nih.gov/pubmed/26028960
http://dx.doi.org/10.2147/BTT.S53361

Ejemplares similares